Pharma news
Pharma
The Court of Justice of the European Union has handed down its decision in Royalty Pharma, providing highly-anticipated guidance on supplementary protection certificates. 30 April 2020
Americas
Foreign patents protecting COVID-19 treatments may stall efforts to protect citizens, says Mark Engelman of Hardwicke chambers. 30 April 2020
Pharma
Gilead has escalated its dispute with the US federal government by filing a new lawsuit accusing it of improperly filing for patents covering HIV drug Truvada. 29 April 2020
Americas
3M has convinced a US judge to grant a restraining order against a New Jersey company it has accused of infringing the 3M trademarks by reselling N95 masks at “grossly inflated” prices amid the COVID-19 pandemic. 27 April 2020
Pharma
Massachusetts-based pharmaceutical company Akebia has had five Fibrogen patents for an anaemia treatment invalidated at the English High Court. 23 April 2020
Americas
The US Court of Appeals for the Federal Circuit has affirmed a lower court’s decision which found that Banner Life Sciences wasn’t infringing a Biogen patent with its bioequivalent version of a multiple sclerosis drug. 23 April 2020
Pharma
The COVID-19 pandemic is heightening the dangers posed by the global trade in counterfeit pharmaceutical products, according to the OECD and EUIPO. 22 April 2020
Pharma
Pressure is building on IP owners to offer up access to technology that could help fight COVID-19. Rory O'Neill looks at some of the implications for the patent system. 21 April 2020
Americas
A total of 79 vaccines and 155 drugs are currently being developed across the globe to combat COVID-19, according to statistics from the Austrian Institute for Health Technology Assessment. 21 April 2020
Pharma
New legislation has been enacted to help in the efforts to deal with the COVID-19 outbreak, as Daphne Lainson and Nancy Pei of Smart & Biggar report. 21 April 2020